Related references
Note: Only part of the references are listed.Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization
Pavithra Dedigama-Arachchige et al.
MODERN PATHOLOGY (2020)
Genetically Engineered Mouse Models of Prostate Cancer in the Postgenomic Era
Juan M. Arriaga et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Molecular Subtypes of Prostate Cancer
Kaveri Arora et al.
CURRENT ONCOLOGY REPORTS (2018)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
Diana Mesquita et al.
ONCOTARGET (2015)
TMPRSS2: ERG blocks neuroendocrine and luminal cell differentiation to maintain prostate cancer proliferation
Z. Mounir et al.
ONCOGENE (2015)
Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology Committee
Michael Ittmann et al.
CANCER RESEARCH (2013)
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
Esther Baena et al.
GENES & DEVELOPMENT (2013)
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss
Yu Chen et al.
NATURE MEDICINE (2013)
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
Alvaro Aytes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer
Paula Paulo et al.
GENES CHROMOSOMES & CANCER (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
TMPRSS2- Driven ERG Expression In Vivo Increases Self-Renewal and Maintains Expression in a Castration Resistant Subpopulation
Orla M. Casey et al.
PLOS ONE (2012)
Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
A. Pellecchia et al.
ONCOGENESIS (2012)
Common Gene Rearrangements in Prostate Cancer
Mark A. Rubin et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
Anthony G. Clementz et al.
BREAST CANCER RESEARCH (2011)
LKB1/PEA3/Delta Np63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure
Edward A. Ratovitski
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Induction of Prostatic Intraepithelial Neoplasia and Modulation of Androgen Receptor by ETS Variant 1/ETS-Related Protein 81
Sook Shin et al.
CANCER RESEARCH (2009)
ETS rearrangements and prostate cancer initiation
Brett S. Carver et al.
NATURE (2009)
Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
Jennifer C. King et al.
NATURE GENETICS (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
Yang Zong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome
G. Somlo et al.
ANNALS OF ONCOLOGY (2008)
Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer.
Karin G. Hermans et al.
CANCER RESEARCH (2008)
A fluorescence in situ hybridization screen for E26 transformation-specific aberrations:: Identification of DDX5-ETV4 fusion protein in prostate cancer
Bo Han et al.
CANCER RESEARCH (2008)
CDK inhibitors: Cell cycle regulators and beyond
Arnaud Besson et al.
DEVELOPMENTAL CELL (2008)
A causal role for ERG in neoplastic transformation of prostate epithelium
Olga Klezovitch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Isabel M. Chu et al.
NATURE REVIEWS CANCER (2008)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription
Jianhai Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1
Zhenming Yu et al.
MOLECULAR CARCINOGENESIS (2006)
LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer
Sunil Upadhyay et al.
CANCER RESEARCH (2006)
ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion
AC Moss et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors
CK Galang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the bar harbor meeting of the mouse models of human cancer consortium prostate pathology committee
SB Shappell et al.
CANCER RESEARCH (2004)
p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer
SF Shariat et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Activation of the WT1 tumor suppressor gene promoter by Pea3
MT Discenza et al.
FEBS LETTERS (2004)
E1AF, an ets-oncogene family transcription factor
M Shindoh et al.
CANCER LETTERS (2004)
Association of ets-related transcriptional factor EIAF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer
S Horiuchi et al.
JOURNAL OF PATHOLOGY (2003)
Clinical significance of p21 expression in non-small-cell lung cancer
T Shoji et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Relationship of p21WAF-1 protein expression with prognosis in advanced prostate cancer treated by androgen ablation
EA Omar et al.
PROSTATE (2001)
Expression of E1AF/PEA3, an ETS-related transcription factor in human non-small-cell lung cancers: Its relevance in cell motility and invasion
H Hiroumi et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation
XT Wu et al.
MECHANISMS OF DEVELOPMENT (2001)
Regulation of Ets function by protein-protein interactions
RZ Li et al.
ONCOGENE (2000)
Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
JR Graff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis
XM Xing et al.
NATURE MEDICINE (2000)
Share Paper
